by nms-sync | Jun 30, 2021 | News
Nerviano, 30 June 2021
Accelera Srl and BiomimX® Srl have signed a non-exclusive commercial agreement following an intense scientific collaboration aimed at introducing and applying new technological solutions to the drug discovery process.
The...
by nms-sync | May 17, 2021 | News
Nerviano, 17 May 2021 The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years.
Our specializations, preclinical and early phase clinical development respectively, our shared...
Recent Comments